• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭治疗开发的“精益”病例报告表设计。

Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.

机构信息

Inova Heart and Vascular Institute, Falls Church, Virginia.

Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

出版信息

JACC Heart Fail. 2019 Nov;7(11):913-921. doi: 10.1016/j.jchf.2019.07.001. Epub 2019 Aug 7.

DOI:10.1016/j.jchf.2019.07.001
PMID:31401097
Abstract

The development of treatments for heart failure (HF) is challenged by burdensome clinical trials. Reducing the need for extensive data collection and increasing opportunities for data compatibility between trials may improve efficiency and reduce resource burden. The Heart Failure Collaboratory (HFC) multi-stakeholder consortium sought to create a lean case report form (CRF) for use in HF clinical trials evaluating cardiac devices. The HFC convened patients, clinicians, clinical researchers, the U.S. Food and Drug Administration (FDA), payers, industry partners, and statisticians to create a consensus core CRF. Eight recent clinical trial CRFs for the treatment of HF from 6 industry partners were analyzed. All CRF elements were systematically reviewed. Those elements deemed critical for data collection in HF clinical trials were used to construct the final, harmonized CRF. The original CRFs included 176 distinct data items covering demographics, vital signs, physical examination, medical history, laboratory and imaging testing, device therapy, medications, functional and quality of life assessment, and outcome events. The resulting, minimally inclusive CRF device contains 75 baseline data items and 6 events, with separate modular additions that can be used depending on the additional detail required for a particular intervention. The consensus electronic form is now freely available for use in clinical trials. Creation of a core CRF is important to improve clinical trial efficiency in HF device development in the United States. This living document intends to reduce clinical trial administrative burden, increase evidence integrity, and improve comparability of clinical data between trials.

摘要

心力衰竭 (HF) 治疗方法的开发面临着临床试验负担过重的挑战。减少对广泛数据收集的需求,并增加试验之间数据兼容性的机会,可能会提高效率并减轻资源负担。心力衰竭协作组 (HFC) 多利益相关者联盟旨在为评估心脏设备的心力衰竭临床试验创建精简的病例报告表 (CRF)。HFC 召集了患者、临床医生、临床研究人员、美国食品和药物管理局 (FDA)、支付方、行业合作伙伴和统计学家,以创建共识核心 CRF。分析了来自 6 家行业合作伙伴的最近 8 项用于治疗 HF 的临床试验 CRF。对所有 CRF 元素进行了系统审查。那些被认为对 HF 临床试验数据收集至关重要的元素被用于构建最终的、协调一致的 CRF。原始 CRF 包括 176 个不同的数据项,涵盖人口统计学、生命体征、体格检查、病史、实验室和影像学检查、设备治疗、药物、功能和生活质量评估以及结果事件。由此产生的最小包容性 CRF 设备包含 75 个基线数据项和 6 个事件,还有单独的模块化附加项,可以根据特定干预措施所需的额外详细信息进行使用。共识电子表格现在可免费用于临床试验。在美国,创建核心 CRF 对于改善 HF 设备开发临床试验的效率非常重要。这份活文档旨在减轻临床试验的行政负担,提高证据完整性,并提高试验之间临床数据的可比性。

相似文献

1
Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.心力衰竭治疗开发的“精益”病例报告表设计。
JACC Heart Fail. 2019 Nov;7(11):913-921. doi: 10.1016/j.jchf.2019.07.001. Epub 2019 Aug 7.
2
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.心力衰竭治疗评估的标准化定义:心力衰竭协作组和学术研究联盟的科学专家小组。
Eur J Heart Fail. 2020 Dec;22(12):2175-2186. doi: 10.1002/ejhf.2018. Epub 2020 Nov 13.
3
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium.心力衰竭治疗评估的标准化定义:心力衰竭协作组和学术研究联合会的科学专家小组。
JACC Heart Fail. 2020 Dec;8(12):961-972. doi: 10.1016/j.jchf.2020.10.002. Epub 2020 Nov 13.
4
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.改善美国心力衰竭治疗药物研发:心力衰竭合作研究室。
J Am Coll Cardiol. 2018 Jan 30;71(4):443-453. doi: 10.1016/j.jacc.2017.11.048.
5
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.经导管房间隔分流装置治疗射血分数保留的心力衰竭(REDUCE LAP-HF I [降低心力衰竭患者左心房压力]):一项 2 期、随机、假手术对照试验。
Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.
6
Device therapy for heart failure.心力衰竭的器械治疗
Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. doi: 10.1016/s0002-9149(02)03380-5.
7
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).用于治疗心力衰竭的经导管房间隔分流装置:降低心力衰竭患者升高的左心房压力的随机试验(REDUCE LAP-HF I)的原理与设计
Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.116.003025.
8
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]).大型心力衰竭临床试验(β-受体阻滞剂生存试验[BEST])中研究者病例报告表或裁决委员会确定住院类型。
Am Heart J. 2010 Oct;160(4):649-54. doi: 10.1016/j.ahj.2010.07.004.
9
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel.功能性和症状性临床终点:HFC-ARC 科学专家小组。
JACC Heart Fail. 2022 Dec;10(12):889-901. doi: 10.1016/j.jchf.2022.09.012. Epub 2022 Nov 9.
10
Current Role of the CardioMEMS Device for Management of Patients with Heart Failure.心力衰竭患者管理中心肌力学监测仪设备的当前作用。
Curr Cardiol Rep. 2019 Jul 27;21(9):98. doi: 10.1007/s11886-019-1194-9.

引用本文的文献

1
A NoSQL document based eCRF system for study of vaccines with variable adverse events case study on COVID19 vaccines.一种用于研究具有可变不良事件的疫苗的基于NoSQL文档的电子病例报告表系统——以COVID-19疫苗为例的案例研究
Sci Rep. 2025 Jul 1;15(1):20453. doi: 10.1038/s41598-025-05746-y.
2
Measures to Improve Trial Enrollment: It's Game Time!提高试验入组率的措施:是时候行动了!
JACC Heart Fail. 2024 Nov;12(11):1942-1945. doi: 10.1016/j.jchf.2024.08.006. Epub 2024 Sep 11.
3
Rethinking heart failure clinical trials: the heart failure collaboratory.
重新思考心力衰竭临床试验:心力衰竭协作实验室
Front Cardiovasc Med. 2024 Jan 24;11:1350569. doi: 10.3389/fcvm.2024.1350569. eCollection 2024.
4
Opportunities and challenges in heart rhythm research: Rationale and development of an electrophysiology collaboratory.心律失常研究中的机遇与挑战:电生理学协作实验室的原理与发展。
Heart Rhythm. 2022 Nov;19(11):1927-1945. doi: 10.1016/j.hrthm.2022.08.004.
5
Consensus minimum core data elements adapted to peripheral vascular intervention in the drug-eluting era: Consensus report from the Registry Assessment of Peripheral Interventional Devices (RAPID) Pathways "LEAN" working group.共识最小核心数据元素适应药物洗脱时代外周血管介入:来自登记评估外周介入设备(RAPID)途径“LEAN”工作组的共识报告。
J Vasc Surg. 2023 Nov;78(5):1313-1321. doi: 10.1016/j.jvs.2023.07.050. Epub 2023 Jul 29.
6
Development of otology specific outcome measure: Ear Outcome Survey-16 (EOS-16).耳科学特定结局指标的开发:耳部结局调查问卷-16(EOS-16)。
J Otol. 2021 Jul;16(3):150-157. doi: 10.1016/j.joto.2021.01.003. Epub 2021 Jan 20.
7
Heart Failure Management Innovation Enabled by Electronic Health Records.电子健康记录促进心力衰竭管理创新。
JACC Heart Fail. 2020 Mar;8(3):223-233. doi: 10.1016/j.jchf.2019.09.008. Epub 2020 Jan 8.